Quick Answer
CYTOKINETICS INC reported Operating Income of -$612.26 million for fiscal year 2025.
CYTOKINETICS INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$612.26M | -14.2% |
| 2024 | -$536.25M | -8.1% |
| 2023 | -$496.20M | -53.1% |
| 2022 | -$324.20M | -74.0% |
| 2021 | -$186.31M | -98.3% |
| 2020 | -$93.94M | +5.0% |
| 2019 | -$98.87M | -11.2% |
| 2018 | -$88.92M | +21.6% |
| 2017 | -$113.40M | -706.8% |
| 2016 | $18.69M | +150.0% |
| 2015 | -$37.41M | -153.5% |
| 2014 | -$14.75M | +56.5% |
| 2013 | -$33.89M | +16.2% |
| 2012 | -$40.46M | +15.7% |
| 2011 | -$47.96M | +3.4% |
| 2010 | -$49.63M | -290.2% |
| 2009 | $26.09M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$166.75M | -18.4% | -49.5% |
| June 30, 2025 | -$111.51M | +14.3% | +28.4% |
| March 31, 2025 | -$155.63M | -23.3% | -10.5% |
| September 30, 2024 | -$140.80M | -15.2% | -8.2% |
| June 30, 2024 | -$130.17M | -6.7% | -3.1% |
| March 31, 2024 | -$126.23M | -1.4% | -3.2% |
| September 30, 2023 | -$122.27M | -12.7% | -0.2% |
| June 30, 2023 | -$122.05M | -1022.4% | +1.9% |
- CYTOKINETICS INC showed a decrease of -14.2% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, CYTOKINETICS INC’s operating income has declined by 2446.3% (from $26.09 million to -$612.26 million).
- The most recent figure is from CYTOKINETICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: